| Amlak Bantikassegn, MD | |
|
201 E Grover St, Shelby, NC 28150-3917 | |
| (980) 487-3678 | |
| Not Available |
| Full Name | Amlak Bantikassegn |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 201 E Grover St, Shelby, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326676453 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2023-00273 (North Carolina) | Primary |
| 207R00000X | Internal Medicine | 2023-00273 (North Carolina) | Secondary |
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Most cancer patients die of the disease because tumor cells spread to other sites in the body and form new tumors, so-called metastases.
"A gunman shot and killed one policeman and wounded another on Wednesday as they provided security for a team of polio eradication health workers in northwestern Pakistan, according to government officials," the New York Times reports (Masood, 4/10).
Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Scientists have developed the first genetically altered monkey model that replicates some symptoms observed in patients with Huntington's disease, according to a new study funded by the National Institutes of Health. Researchers are now able to better understand this complex, devastating and incurable genetic disorder affecting the brain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amlak Bantikassegn, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Amlak Bantikassegn, MD 201 E Grover St, Shelby, NC 28150-3917 Ph: (980) 487-3678 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Most cancer patients die of the disease because tumor cells spread to other sites in the body and form new tumors, so-called metastases.
"A gunman shot and killed one policeman and wounded another on Wednesday as they provided security for a team of polio eradication health workers in northwestern Pakistan, according to government officials," the New York Times reports (Masood, 4/10).
Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Scientists have developed the first genetically altered monkey model that replicates some symptoms observed in patients with Huntington's disease, according to a new study funded by the National Institutes of Health. Researchers are now able to better understand this complex, devastating and incurable genetic disorder affecting the brain.
› Verified 7 days ago
Eric Ofosu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 | |
Robert John Bentley Mcloughlin, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 | |
Marcel Ikwuoma Akuneme, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 | |
Swachetan Singh Bajwa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 | |
Nnenna Uchendu, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 | |
Naa Deisa Abbey, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 |